Javier B. Pérez Serrano

Dr. Javier B. Pérez Serrano

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 May 2022 in European Journal of Clinical Microbiology & Infectious Diseases
Verified
Journal Article
Closed access
PDF file
AJAdrián Jerónimo
Adrián Jerónimo
COCarmen Olmos
Carmen Olmos
IVIsidre Vilacosta
Isidre Vilacosta
CSCarmen Sáez
Carmen Sáez
JLJavier López-Díaz
Javier López-Díaz
JCJosé Alberto San Román Calvar
José Alberto San Román Calvar

18 October 2024 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
ALAdrián Lozano
Adrián Lozano
PPPaloma Pulido
Paloma Pulido
JLJavier López-Díaz
Javier López-Díaz
MMMaría De Miguel
María De Miguel
GCGonzalo Cabezon
Gonzalo Cabezon
JCJosé Alberto San Román Calvar
José Alberto San Román Calvar
Background/Objectives: Heart failure worsens the prognosis of patients with infective endocarditis (IE) and is mainly caused by severe valvular regurgitation. The aim of our investigation is to describe the clinical, epidemiological, microbiological, and echocardiographic characteristics of patients with native left-sided infective endocarditis (NLSIE) with severe valvular regurgitation; to describe the prognosis according to the therapeutic approach; and to determine the prognostic factors of in-hospital mortality. Methods: We prospectively recruited all episodes of possible or definite NLSIE diagnosed at three tertiary hospitals between 2005 and 2022. Patients were divided into two groups: patients with severe valvular regurgitation at the time of admission or during hospitalization and patients without severe valvular regurgitation. We analyzed up to 85 variables concerning epidemiological, clinical, analytical, microbiological, and echocardiographic data. Results: We recovered 874 patients with NLSIE, 564 (65%) of them with severe valvular regurgitation. There were no differences in mortality among patients with and without severe regurgitation (30.2% vs. 26.5%, p = 0.223). However, mortality increased when patients with severe regurgitation developed heart failure (33% vs. 11.4%, p < 0.001). Independent factors related to heart failure were age (OR 1.02 [1.01–1.034], p = 0.001), anemia (OR 1.2 [1.18–3.31], p = 0.01), atrial fibrillation (OR 2.3 [1.08–4.89], p = 0.03), S. viridans-related IE (OR 0.47 [0.3–0.73], p = 0.001), and mitroaortic severe regurgitation (OR 2.4 [1.15–5.02], p = 0.019). Conclusions: Severe valvular regurgitation is very frequent among patients with NLSIE, but it does not worsen the prognosis of patients unless complicated with heart failure.

22 August 2023 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
GCGonzalo Cabezon
Gonzalo Cabezon
MÁMaría de Miguel Álava
María de Miguel Álava
JLJavier López-Díaz
Javier López-Díaz
IVIsidre Vilacosta
Isidre Vilacosta
PPPaloma Pulido
Paloma Pulido
JCJosé Alberto San Román Calvar
José Alberto San Román Calvar
Studies focused on the clinical profile of native valve endocarditis are scarce and outdated. In addition, none of them analyzed differences depending on the causative microorganism. Our objectives are to describe the clinical profile at admission of patients with left-sided native valve infective endocarditis in a contemporary wide series of patients and to compare them among the most frequent etiologies. To do so, we conducted a prospective, observational cohort study including 569 patients with native left-sided endocarditis enrolled from 2006 to 2019. We describe the modes of presentation and the symptoms and signs at admission of these patients and compare them among the five more frequent microbiological etiologies. Coagulase-negative Staphylococci and Enterococci endocarditis patients were the oldest (71 ± 11 years), and episodes caused by Streptococci viridans were less frequently nosocomial (4%). The neurologic, cutaneous or renal modes of presentation were more typical in Staphylococcus aureus endocarditis (28%, p = 0.002), the wasting syndrome of Streptococcus viridans (49%, p < 0.001), and the cardiac in Coagulase-negative Staphylococci, Enterococci and unidentified microorganism endocarditis (45%, 49% and 56%, p < 0.001). The clinical signs agreed with the mode of presentation. In conclusion, the modes of presentation and the clinical picture at admission were tightly associated with the causative microorganism in patients with left-sided native valve endocarditis.

12 August 2026 in European Journal of Internal Medicine
Verified
Journal Article
Open access
PRPablo Rodríguez-Cortés
Pablo Rodríguez-Cortés
ECElena Arranz Canales
Elena Arranz Canales
AÁAlexia Constanza Espiño Álvarez
Alexia Constanza Espiño Álvarez
JSJavier B. Pérez Serrano
Javier B. Pérez Serrano
LRLaura Rabes-Rodríguez
Laura Rabes-Rodríguez
FSFernando Sebastian-Valles
Fernando Sebastian-Valles

29 September 2026 in Open Forum Infectious Diseases
Verified
Journal Article
Open access
JGJesús Troya García
Jesús Troya García
NCNoemí Cabello-Clotet
Noemí Cabello-Clotet
JSJose Ignacio Bernardino de la Serna
Jose Ignacio Bernardino de la Serna
MGMaría José Galindo
María José Galindo
RMRosa María Martínez
Rosa María Martínez
RCRelativity Cohort
Relativity Cohort
Background: Immune and virological trajectories after switching to long-acting cabotegravir plus rilpivirine (CAB+RPV LA) remain incompletely characterized in routine care settings. Methods: We analyzed virologically suppressed adults switching to CAB+RPV LA in the Spanish multicenter RELATIVITY cohort. Paired CD4+, CD8+, and CD4/CD8 measurements were assessed at approximately 12 and 24 months and at the last available immune assessment. Analyses used a 1.0 ratio threshold and incorporated longitudinal HIV-1 RNA, recorded geographic origin, pre-switch suppression duration, and immediate pre-switch antiretroviral therapy. Results: Among 3349 participants, the last paired-ratio assessment (n = 2929) occurred at a median of 22 months (IQR, 16–27). Median changes were −7 cells/mm3 (IQR, −138 to +117; n = 2992) for CD4+ T-cell count, −60 cells/mm3 (IQR, −214 to +75; n = 2941; P < .001) for CD8+ T-cell count, and +0.07 (IQR, −0.05 to +0.20; n = 2929; P < .001) for the CD4/CD8 ratio. Baseline CD4/CD8 <1.0 was independently associated with greater ratio increase (adjusted beta, +0.060; 95% CI, +.030 to +.090; P < .001). Longer pre-switch suppression and any post-switch HIV-1 RNA ≥50 copies/mL were associated with smaller ratio increases. Adjudicated virological failure occurred in 28/3349 (0.8%). Findings persisted among participants with all recorded post-switch HIV-1 RNA values <50 copies/mL and after excluding protocol-defined virological failure. Conclusions: During effective CAB+RPV LA maintenance, CD4+ T-cell counts showed no meaningful change, while a modest decline in CD8+ T-cell counts was accompanied by a small CD4/CD8 ratio increase. These descriptive changes are compatible with continued immune evolution during sustained suppression and do not establish a CAB+RPV-specific effect or justify additional routine T-cell-subset monitoring.

5 October 2026 in Medical Mycology Case Reports
Verified
Journal Article
Open access
IGInigo Vázquez Gomara
Inigo Vázquez Gomara
JSJavier B. Pérez Serrano
Javier B. Pérez Serrano
MCMa Auxiliadora Semiglia Chong
Ma Auxiliadora Semiglia Chong
LVLidia Vilches-Miguel
Lidia Vilches-Miguel
DCDiego Real de Asua Cruzat
Diego Real de Asua Cruzat
PRPablo Rodriguez-Cortes
Pablo Rodriguez-Cortes